The case presented here demonstrates a remarkable response to chemoimmunotherapy in a patient with metastatic ESCC, dMMR due to isolated PMS2 loss, and a low but positive PD-L1 CPS of 1. This evidence concerns the gene CD274 and esophageal squamous cell carcinoma.